Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

8,823 evidence items · page 158 / 353

5.6 %HIV prevalence was significantly higher in females (5.6%) than males (3.7%) aged 15 years and older in the Akwa Ibom AIDS Indicator Survey.

NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 4 observations

39,000,000 peopleAt the end of 2022, 39.0 million people were living with HIV worldwide.

NigeriaVIH/sidaobserved 2022published 2024BMC infectious diseasesPubMeddocument of 4 observations

26.2 per_100000Cervical cancer is the second most common cancer amongst women in Nigeria, with an incidence rate of 26.2 per 100,000.

Nigeriacancer du col de l'utéruspublished 2025The Pan African medical journalPubMeddocument of 10 observations

53.3 %Among 300 non-diabetic respondents in a cross-sectional survey, 160 (53.3%) were at high risk of developing type 2 diabetes.

Nigeriadiabète de type 2published 2021African health sciencesPubMeddocument of 10 observations

592 casesFrom 2016 to 2018 in Egor, Oredo, and Uhunmwonde LGAs of Edo state, Nigeria, 592 (57.6%) of the 1,045 new cancers were in females.

Nigeriacancer (non précisé)observed 2016 to 2018published 2024BMC public healthPubMeddocument of 8 observations

Gametocyte densities were significantly higher by days 3–7 following treatment compared with pre-treatment among children treated with amodiaquine for uncomplicated Plasmodium falciparum malaria.

Nigeriapaludismeobserved 2000 - 2006published 2008Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/1475-2875-7-169

70.5 %Among medical doctors in Ebonyi state, Nigeria, 70.5% had fair knowledge of the 2015 National Guidelines for Diagnosis and Treatment of Malaria.

Nigeriapaludismeobserved 2019published 2021PloS onePubMeddocument of 11 observations

45.33 %45.33% of participants recognized fever with shivering/sweating as the most common malaria symptom.

Nigeriapaludismepublished 2025Scientific reportsPubMeddocument of 14 observations

9.9 %The hepatitis B prevalence in conflict zones in Nigeria was 9.9%.

Nigeriahépatite Bobserved 2018published 2021Annals of global healthPubMeddocument of 12 observations

100 %Sensitivity and specificity for 24-hour HIV viral load testing using BD Vacutainer PPT were both 100%.

NigeriaVIH/sidapublished 2025The journal of applied laboratory medicinePubMeddocument of 3 observations

87 %Retinal reattachment rate was 87% for PVR D eyes.

Nigeriaproliferative vitreoretinopathyobserved 2005–2012published 2020Nigerian journal of clinical practicePubMeddocument of 11 observations

100 %Days 14 and 28 parasitologic cure rates were 100% (34 of 34) and 96.2% (25 of 26) for children treated with dihydroartemisinin suppository.

Nigeriapaludismepublished 2007The American journal of tropical medicine and hygieneeurope_pmcdocument of 2 observationsDOI 10.4269/ajtmh.2007.76.1

31 %Among 436 treatment-naïve Nigerian breast cancer patients, 31% had luminal A breast cancer.

Nigerialuminal A breast cancerpublished 2026Breast cancer research and treatmentPubMeddocument of 14 observations

42.7 %The prevalence of HbAA without alpha gene deletion was 42.7% among healthy controls.

NigeriaHbAApublished 2022Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument of 17 observationsDOI 10.4084/mjhid.2022.001

53 %A review of January to September 2021 showed a test positivity rate (TPR) decline from 53% to 50% at Secondary Health Facilities (SHFs).

Nigeriapaludismeobserved January to September 2021published 2025Malaria journalPubMeddocument of 9 observations

All clinics continued to receive support for first and second line antiretrovirals and CD4 testing after the PEPFAR policy change.

NigeriaVIH/sidaobserved October 2014–September 2015published 2019PloS onePubMeddocument of 11 observations

37 participantsAll 37 participants at week 48 were fully or mostly satisfied with the intervention among youth with HIV in Nigeria in a single-arm trial.

NigeriaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 12 observations

23.7 %Awareness of the malaria vaccine was low, with only 89 mothers (23.7%) reporting prior knowledge of it.

Nigeriapaludismepublished 2025BMJ openPubMeddocument of 4 observations

10 %The age- and sex-standardised prevalence of chronic kidney disease (CKD) among antiretroviral therapy (ART)-naïve people living with HIV (PLWH) in Lagos, Nigeria ranged from 10.0% to 17.6%.

Nigeriamaladie rénale chroniquepublished 2024BMC nephrologyPubMeddocument of 15 observations

3.2 %Only 3.2% of women in urban slums of Lagos, Nigeria had heard of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 13 observations

91 paysLe paludisme est présent dans 91 pays à risque.

NigeriapaludismeHAL · Unilimdocument of 173 observations

73.2 %73.2% of women in Taraba, North-East Nigeria had appropriate knowledge about the nature of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 6 observations

7.5 %Left ventricular hypertrophy was observed in 7.5%–10% of children with HIV-associated heart disease.

NigeriaHIV-associated heart diseasepublished 2025The Nigerian postgraduate medical journalPubMeddocument of 10 observations

10.4 yearsThe mean age at onset of pubic hair development (Tanner stage PH2) was 10.4 years in girls with haemoglobin AA.

Nigeriahaemoglobin AApublished 2023West African journal of medicinePubMeddocument of 7 observations

113 government_personnelHoward University Global Initiative, Nigeria developed the capacity of 113 top government personnel as Master Trainers on Pharmaceutical Care in HIV/AIDS.

NigeriaVIH/sidapublished 2025Currents in pharmacy teaching & learningPubMeddocument of 9 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.